Summary
- Profile Type
- Business Offer
- POD Reference
- BORS20250505008
- Term of Validity
- 5 May 2025 - 5 May 2026
- Company's Country
- Serbia
- Type of partnership
- Commercial agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
-
The Serbian company provides specialized data and software services for biotech and pharmaceutical companies, with a strong focus on market access, pricing, and contract research organization (CRO) support.
The company is looking for agents and partners for subcontracting through commercial agreement. - Full Description
-
The Serbian company is specialized in providing advanced software development, data engineering, and AI-powered analytics tailored for the life sciences sector. Founded in 2022, the company has 15+ years of experience working with contract research organizations (CROs), clinical data teams, and digital health innovators. The company delivers highly customized solutions that support data integration, real-time analytics, compliance, and infrastructure automation. Their team includes certified experts in cloud architecture, DevOps, data science, and regulatory-compliant software delivery.
The company offers its core service – CRO-style support, with a strong focus on enabling CROs to modernize and streamline their data and technology operations. Rather than delivering generic products, the company builds purpose-specific tools that fit into CRO workflows, including:
● Custom software systems for managing clinical trial data, patient tracking, and operational metrics
● Data engineering pipelines for ingesting, transforming, and harmonizing structured and unstructured health data
● ETL and analytics solutions for preparing regulatory-ready reports and dashboards
● DevOps and cloud infrastructure modernization, including CI/CD pipelines, Infrastructure-as-Code (IaC), and monitoring
● AI/ML models and automation, especially for NLP (Natural Language Processing), prediction and decision support
The company collaborates with CROs to serve their clients more effectively—especially in cases where scalability, speed, and auditability are critical.
The company is looking for partners through commercial agreements. Specifically, it seeks CRO companies that need a capable technical partner to handle data-heavy, regulated, or infrastructure-intensive projects. The company provides back-end delivery, while the CRO leads the client relationship. As part of the partnership, the company offers:
● Complete technical design and execution
● Dedicated project and compliance leads
● Sprint-based reporting and communication
● Tools and codebases fully integrated with partner infrastructure
The company also acts as a subcontractor, delivering concrete outputs such as monthly data pipelines, clinical dashboards, regulatory documentation tools, or full DevOps environments. Deliverables are defined contractually, with clear timelines, audit logs, and compliance measures. - Advantages and Innovations
-
The company has following advantages:
• Strong team with 15+ years of experience in biotech, pharma, and healthcare data management
• Active presence in multiple international markets including Balkan, Austria and US
• Member of multiple industry networks and ecosystem platforms (Flanders.bio - MEDVIA, Scanbalt, BIO4 Campus Belgrade)
• Flexibility and proven success in outsourced and subcontracted 20 projects
The service has following advantages:
• Integrated approach to data management, regulatory documentation, and decision-maker insights
• Dedicated CRO support services, tailored for biotech startups and pharma companies
• Transparent reporting, including structured monthly deliverables
• Clear deliverables and service level agreement (SLAs) in all cooperation models - Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 17: Partnerships to achieve the Goal
Partner Sought
- Expected Role of a Partner
-
Type: Industrial partner: 1. Agents and representatives in biotech and pharma fields, and 2. Biotech companies seeking reliable data and CRO partners.
Role:
It is expected from agents to promote and negotiate contracts for the company’s services in local markets. They are expected to have experience in pharmaceutical or biotech industry, particularly in market access, health economics, or data analysis. Partners with networks in EU/EEA life sciences sectors are preferred.
It is expected from the biotech/pharma companies who engage the company as their subcontractor to utilize company’s CRO services to streamline pricing, documentation, and market access. - Type and Size of Partner
- SME <=10
- SME 11-49
- SME 50 - 249
- Type of partnership
- Commercial agreement
Dissemination
- Market keywords
- 05007007 - Other medical/health related (not elsewhere classified)
- 05005022 - Other clinical medicine
- Targeted countries
- All countries